Biologicals

Technical report series: cytokines

Biological products, rDNA

Title: Biological products prepared by recombinant DNA technology; Adopted 1990, TRS No 814, Annex 3

Interferons, human

Title: Requirements for Human Interferons prepared from Lymphoblastoid Cells; Adopted 1988, TRS No 786, Annex 3

Interferons, human

Title: Requirements for Human interferons made by recombinant DNA techniques; Adopted 1987, TRS No 771, Annex 7

UPCOMING EVENTS

WHO Drafting Group Meeting on the Revision of TRS 962, Annex 1

(Guidelines to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines) 29-30 April 2014, WHO/HQ, Geneva

Implementation Workshop on Evaluation of Biotherapeutic Products and Evaluation of Similar Biotherapeutic products with emphasis on Monoclonal Antibody Products

13-16 May 2014, Seoul, The Republic of Korea

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971